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ABSTRACT
We have all read that: (1) organized medicine was laughing at the germ theory and 
refused to wash its hands in the late 1800's while women died of childbed fever and 
other patients of wound sepsis (scientists in general, including physicists, were among 
those who died); and (2)  during the 1900's, and still today, organized medicine is 
laughing at the essential nutrient theory.  We now hear the medical quality assurance 
boards enforce MANY MISTAKEN VIEWS and DO NOT recognize that: "xenobiotics 
can't be substituted for essential nutrients; ascorbic acid is NOT a vitamin and hence, is 
needed in multi-gram (not minute amounts) for optimum health; there is great harm in 
a diet deriving half its calories from refined carbohydrates as is common in the US 
today; dietary correction is possible at a stage when surgery is contemplated for a 
cardiac patient; mercury dental fillings and even the high-copper variety most widely 
used are extremely unsafe;" etc.  The purpose of this manuscript is to elicit coordinated 
collective effort of physicists, other scientists and the Union of Concerned Scientists to 
educate the public and end this tyranny of organized medicine whose methods are 
reported to cause much M&M (over a million unnecessary US deaths at a cost of many 
billion dollars annually).  The biochemistry of these errors would be trivial to 
understand for physicists and other scientists (who are all still going innocently to 
slaughter among those dying needlessly, even today).
List of Abbreviations
AA = ascorbic acid, ascorbate
AGC = aggressive glycemic control
CDC = Centers for Disease Control
cmi = cell mediated immunity 
cvd = cardiovascular disease
GAA = glucose ascorbate antagonism
GHb = glycated hemoglobin
g/d = grams per day
HMS = hexose monophosphate shunt
iv = intravenous
LANL = Los Alamos National Laboratory
M&M = morbidity and mortality
mg% = mg/dL = mg/deciliter = mg percent
rCHO = refined carbohydrate
TOC = treatment of choice
UCS = Union of Concerned Scientists
wbc = white blood cells
WHO = World Health Organization
 See newly added Chapter 2 on mercury amalgams and Extreme Psychoses (Serial 
Killers with No-Remorse) beginning on page 18.  Note that in what follows, some 
repetition is necessary so that individual sections can be read separately.
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BACKGROUND 
The rationale for publishing this paper on LANL arXiv relates to the roles, 
responsibilities and duties of physicists to protect the society that supports them.  When 
something new and important happens in physics every physicist wants to hear about 
it.  When something new and important happens in medicine, almost no one has time 
to hear about it.  We don't want to villianize physicians; treatments of choice that 
substitute xenobiotics for essential nutrients are reportedly so ineffective that vast 
numbers of patients are dying unnecessarily and physicians cannot take time to indulge 
their natural interest in medicine. If  instead, essential nutrient therapies were used, 
ending the carnage, so few people would be ill that most physicians would be very 
lightly burdened in their practice, which would have become essentially preventive 
medicine. Thus, the purpose of this message will have been accomplished.
Poor Health Status in Nations Using US Medical System 
World Health Report 2000 (WHO 2000), issued in June by the World Health 
Organization, ranks 191 United Nations (UN) member states on the quality, cost, 
etc., of their health care systems.  Although the U.S. spends far more than any 
other nation it is ranked only 37th!  Countries with medical systems most similar to 
the U.S. also scored very poorly:  Australia 32nd, Canada 30th and New Zealand 
41st.  The probability of these four nations grouping  so closely (ie, in a span of only 
12 of 191 rankings) by chance is extremely low, p<0.001 [ie, (12/191)**3].  
Moreover, in spite of the U.S. medical expenditure being far more than any other 
nation, it is ranked 72nd in personal health and NZ, spending more than circa 90% 
of all other nations, is ranked 80th.  It is improbable that these two countries would 
rank so closely by chance (ie, in a span of only 8 of 191 rankings, p<0.05).  Our 
analysis herein shows that the low rankings earned by US style medical systems is 
due almost entirely to impact of errors in modern medicine (i.e., xenobiotics have 
been substituted for essential nutrients which are rejected as unprofitable). It is 
shown below that the vast majority of NZ and US deaths, suffering and 
incapacitation, and cost also result from the same errors, of which ignorance 
regarding hyperglycemia and the "mistaken view " that ascorbic acid (AA) is a 
vitamin are among the most culpable.
In the US, it has been virtually canonical that the practice of medicine is and 
should be a prestigious profession.  In recent decades of health care quality decay 
cited by highly respected authorities (Watson 1973; Relman 1992; Angell 2000), 
physicians of our acquaintance, as individuals, have been highly trained and 
motivated (no one works harder), and would have welcomed new more effective 
modalities, even if unprofitable.  Yet, all of medicine has been losing respect, 
including individual physicians through no fault of their own.  Relevant are public 
expectations of physicians that are not humanly possible to fulfill, e.g., they are 
expected to know what is known (i.e., published in the medical science literature).  
This knowledge has become essentially inaccessible because of its size and growth 
rate.  A large university medical center library receives over 40 million new pages 
per decade from the journals to which it subscribes.  Much of this material is both 
excellent and relevant to clinical medicine.  However, it isn't possible even to turn 
this many pages in a decade.  No clinician (or even researcher) could possibly find 
the time to locate, by any system, and read 1% (40,000 pages/year) of the flood.  
There may be no area of human endeavor where ignorance (of what is known) is 
growing as rapidly as in clinical medicine.
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Ignorance, however, is no excuse for breaking the law.  In medicine, the law 
is derived from the literature.  As demonstrated here: (1) the "complete" literature 
(i.e., ~1935 to date) contains all that is needed to cure most of the major diseases 
with already proven and easily tested modalities; and (2) scientific study of these 
modalities actually defines the laws of nature with respect to medicine.  However, 
the literature also contains vast reams of publications apparently written by 
authors who have ignored the "complete" literature, and are ignorant of the laws of 
nature.  These authors advocate empirical and entirely unscientific, often unsafe 
and inefficacious outmoded treatments called treatments of choice (TOC's) which 
are vigorously enforced by medical disciplinary boards. This has controlled 
medicine and prevented its modernization by modalities that were unpatentable 
and therefore rejected by certain interests as unprofitable (ie, in effect, analogous to 
opposing hand washing ~1850AD).  Thus, TOC's are causally associated with the 
extremely high US M&M and health care costs, and very low WHO rankings.  
There are 200,000 deaths/yr ($18 billion/yr) due to infections; 500,000 due to 
cancer; and 700,000 due to cardiovascular disease.  The total annual bill for the 
"care" producing this toll is reported to be > $1 trillion (> 1/6 of the US national 
debt) (Feltman 1991; CDC 2000).  In addition to this bankrupting cost, it appears 
that as many people die in the U.S. each year due to failure of TOC's as were 
executed annually in Hitler's death camps.  It appalls to hear the expression "Death 
Camp USA".
In Europe between 1840 and 1870, studies conducted by Ignaz Semmelweis, 
John Snow, Louis Pasteur, and Joseph Lister, contributed to the growing science of 
bacteriology (Lederberg 2000).  The germ theory was slow to be transmitted to the 
United States, however.  We have all read that U.S. physicians laughed at the germ 
theory and refused to wash their hands in the late 1800's while women died of 
childbed fever and other patients of wound sepsis.  It was not until the late 1880s 
that antiseptic surgery was started in the US by American surgeon Dr. William 
Mayo in his clinics in Rochester, Minnesota.  There is evidence that some senior 
physicians in U.S. hospitals still had not accepted the germ theory circa 1900 (Price 
1917).  History insists medicine has shown the same characteristic behavior, in the 
1700's denying that blood circulated in the body, then denying the germ theory, 
and recently, in the 20th century denying basic biochemical knowledge regarding 
the science of essential nutrients including that of AA.  Thus, medicine has been 
accused of being both the sole judge of its own quality and historically calloused in 
its slowness to modernize by elimination of long held erroneous views.  In each 
era, these views are reported to vigorously oppose basic facts readily proven from 
the literature to be of great importance and subsequently adopted.  Even now, 
these views are reported to cause immeasurable unnecessary suffering and 
mortality, including a million early deaths in treatment annually in the U.S. 
(Feltman 1991; CDC 2000). 
The similarity between "laughing at the germ theory" and rejecting 
modalities as unprofitable (in spite of higher safety and efficacy) is extremely 
important.  Pauling called such behavior "condemnation without investigation".  
Medicine has an irrevocable sworn duty to act in the best interests of the patient.  
Isn't it criminal either to adopt or continue use of therapies with low safety and 
efficacy, many side effects and high cost (especially when profit is a motive)?  We 
discuss below a sampling of such instances (from a much larger number that exist) 
and ask how can the resulting M&M be justified?  It is also puzzling that medicine 
ignores some matters with more negative impact on human health than did 
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ignorance of the germ theory.  These discussed in later sections, include obvious 
gross changes in glycemic levels in the affluent societies since 1900, and certain 
biochemical problems of humans elucidated by study of other mammals.
Of course, it is clear that many thousands of exemplary physicians have 
humanistic motives and exert themselves to heroic levels, accomplishing much for 
their patients.  However, the complete literature argues that, if the "rejected 
modalities" recommended here were employed, M&M and costs would be far 
lower in the hands of all clinicians, including the large number that are already 
exemplary.  Illustrative examples are Denham Harman, MD, PhD and Abram 
Hoffer, MD, PhD.  As explained (inter alia): (1) Harman showed that both "normal" 
aging and the major life shortening mitochondrial aging could be significantly 
slowed if the "rejected" antioxidants (ascorbate, ubiquinone and vitamins A and E) 
were accepted and properly used; and (2) Hoffer's early work with essential 
nutrients prompted Linus Pauling to coin the term "orthmolecular" (Pauling 1969).
More on the Decline of U.S. Health Care Quality   
The deterioration in personal health from circa 1950 to 1970 was striking and 
quantifiable, but not understood because of fundamental errors in the canonical 
views.  To establish some important temporal aspects of this decay, in addition to 
WHO, we cite six prominent persons (Watson 1973; Relman 1992; Angell 2000; 
Stevens and Glatstein 1996); Trowbridge 1986):
The first is the following statement delivered at the Mayo Clinic in Rochester, 
Minnesota, on 19 November 1970, by Mr. Thomas J. Watson, Jr., CEO of IBM: 
"Let me start by asking a question that this great medical center brings to 
mind: How would you like to live in a country which, according to the figures 
available in the United States during the past two decades: has dropped from 
seventh in the world to sixteenth in the prevention of infant mortality; has dropped 
in female life expectancy from sixth to eighth; has dropped in male life expectancy 
from tenth to twenty-fourth; and which has bought itself this unenviable trend by 
spending more of its gross national product for medical care ($1 out of every $14) 
than any other country on the face of the earth?" 
"You know the country I am talking about: Our own U.S.A., the home of the 
free, the home of the brave, and the home of a decrepit, inefficient, high-priced 
system of medical care. Just look for a moment at what some of the figures mean. 
They mean that in infant mortality we have been overtaken by France, the U.K., 
and Japan, that in male life expectancy we have been overtaken by France, Japan, 
West Germany and Italy. I know experts can disagree over our precise 
international standing. And I realize that medical problems in the United States, 
Europe and Japan are not identical. But the evidence overwhelmingly indicates that 
we are falling down on the job, heading in the wrong direction, and becoming as a 
nation a massive medical disgrace." 
The second is the paragraph below from a 1992 article on health-care reform 
by Arnold S. Relman, MD, long-time Editor-in-Chief of the New England Journal of 
Medicine (NEJM):
"In short, our health-care system, formerly a social service that was the 
responsibility of dedicated professionals and not-for-profit facilities, has become a 
vast, profit-oriented industry. The revenue of this industry constitutes the  
country's  health-care costs.  As in any other industry, providers constantly strive 
to increase their profitable sales, but unlike other industries, consumers exercise 
little control over their consumption of products and services. It should not be 
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surprising that such a system is afflicted not only with relentless inflation but also 
with neglect of the needs of the uninsured and with failure to promote the use of 
valuable but unprofitable health services."
The third is an editorial by Marcia Angell, MD, another former NEJM Editor-
in-Chief, entitled "Is Academic Medicine for Sale?"  She discusses numerous 
involved facets of industry influence that actually affect the fundamental views of 
physicians and the way they practice medicine (i.e.,  "As the critics of medicine so 
often charge, young physicians learn that for every problem, there is a pill ...").  In 
support of the Angell editorial's thesis, as epitomized by this quote, we show below 
examples of the countless tragedies dominating medicine because of the simplistic 
"pill" mindset that is unmindful of homeostasis, the literature and the essential 
nutrients.  
Angell's editorial strongly supports, essentially verbatim, a warning made in 
1983 by the fourth, immunologist Alan S. Levin, MD, JD (Trowbridge 1986).  His 
medical symposium presentation analyzed problems due to industrial control of 
medicine.  He pointed out that a sample issue of possibly the world's largest and 
most prestigious medical journal had 51 pages of scientific matter and 99 pages of 
industry ads.  He said: industry is setting the standard of medical practice and has 
invaded the academic institutions; as much as two-thirds of the research funding in 
most major institutions comes directly or indirectly from industry interests; 
therefore, chemotherapy is dominant, and, unfortunately, immunotherapy is 
secondary. He added that: the market for (sorely needed) immunotherapy in the 
US is only $50 million while the market for (heavily advertised) antihistamines is 
about $2 billion; medicinals are more profitable than any other industrial product; 
the practice of medicine and our medical science are dictated by industry that is 
promoting its own financial welfare.  His talk ended with the following excerpt:
". . . this is no laughing matter . . . We are being taken over by . . . industry. It 
is using the academic institutions to do this. If you don't think so, read any of the 
so-called peer-review journals, and you will realize that they are dominated by . . . 
industry." 
It has been widely asserted that the matters most vital to the people 
including the expense, pain and sorrow endured and their very survival have been 
systematically and relentlessly subordinated to business interests via influence on 
the quality and cost of medical care ((Watson 1973; Relman 1992; Angell 2000; 
Stevens and Glatstein 1996; Trowbridge 1986; Pauling 1969, 1987).  The interests 
refuse to recognize even the tragic failure of the U.S. medical system, let alone 
existence of possible errors in accepted views of biology.  Finally, in an editorial, 
Stevens and Glatstein (1996) have emphasized that our failures to cure the major 
diseases will not yield to more extravagant expenditures if we do not understand 
the biology:
"Beware the Medical-Industrial Complex.
'We must guard against the acquisition of unwarranted influence, whether
sought or unsought, by the military industrial complex.'  Farewell Address of 
Dwight D. Eisenhower, 34th President of the US, January 1961.  If Ike were with us 
today, he might well expand his views on power and influence to include modern 
American medicine. . .  Our true challenge . . . is to understand the biology . . . We 
must not be . .  another special interest come to drink at the well of public spending, 
but as advocates for the public good.  If we fail . . . we will be unable to make any 
important long-term contribution to those who matter most - our patients." 
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SECTION 1.  Glycemic Modulation in Health and Disease.
 Cures of most major disorders have in common the need to keep blood glucose 
in a low range that would be normal among people of undeveloped nations who have 
an unrefined diet.  In his 1969 paper in Science, Linus Pauling coined the term 
"orthomolecular" to describe the interrelationships of molecules normally present in the 
body.   He was largely motivated by the work of Abram Hoffer, MD, PhD, who was 
able to correct a number of disorders including schizophrenia that had been considered 
incurable. An orthomolecular lesion common to many, possibly most, diseases exists 
when blood glucose is high and ascorbic acid is low.
The advent of cheap energy in affluent countries occurred in the late 1800's and enabled 
them to refine foods using fossil fuels. The costs of harvesting and processing food 
became steadily lower.  However, there was no knowledge of the effects of food 
refinement on its essential nutrient content in the early 1900's.  Within two decades after 
the introduction of low cost, shelf stable, refined foods (i.e., white flour, sucrose, etc), 
the first evidence of heart disease appeared .  By mid-century heart disease had become 
the most common cause of death in affluent societies.
An important study by Cheraskin and Ringsdorf (1974) puts all of these facts in 
perspective.  They cite US DA statistics that, in 1970, the average American consumed 
264 pounds of empty calories.  On a dry weight basis, this was just over 50% of food 
intake.  Using the Cornell Medical Index Health Questionnaire (CMIHQ) and a sample 
of 715 well educated people, they created plots of refined carbohydrate  (rCHO) intake 
vs health problems.  Extrapolations of these plots show that zero health problems occur 
at zero rCHO intake.  Consider the implication for staggering increases in M&M and 
dollars that have been caused by rejection of the glycemic control modality provided by 
an unrefined diet.
As stated above, the literature on agriculture, food science, nutrition, and medicine has 
now become almost inaccessible because of its size and growth rate.  Making the wisest 
decision in terms of what to do with food, food processing, or essential nutrient 
supplementation is not trivial. Being sufficiently informed to make advancements in the 
struggle against the effects of fundamental errors is difficult. The general public, 
lawmakers, and researchers must be aware of the errors of affluence and their many 
influences on health. 
Very few can understand the complexities and interactions of food chemistry, nutrition, 
and human disease. A leading exception is the originator of the free radical theory of 
aging, Denham Harman (1969, 1972, 1981), whose chemistry doctorate preceded his 
degree in internal medicine. Harman showed that both ‘normal’ aging and the major 
life-shortening mitochondrial aging could be retarded if the essential nutrient 
antioxidants ascorbate, ubiquinone (Coenzyme Q10), and vitamins A and E were 
properly used. Indeed, we argue that, if adequate levels of all the essential nutrients 
were present in the diet, M&M and their associated costs would be far lower.
In this era, medicine's opposition to modernization has been directed toward essential 
nutrients, a class of modalities that are well defined in the literature but were rejected 
by certain interests as unprofitable in the 20th century. Note that, in effect, rejecting the 
importance of essential nutrients is analogous to opposing hand washing while 
laughing at the germ theory a century earlier (Lederberg 2000; Price 1917). We argue 
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the misconceptions cited above as the cause of the erroneous view on these modalities 
has persisted and subtly permeated all aspects of health care, including medical school 
textbooks. The deterioration in the quality of health from 1950 to 1970 was striking in 
America (despite its prosperity) and quantifiable, but not understood because of the 
widely accepted indifference to the theory of essential nutrients.
Essential Nutrients, Bioenergetics and A Fundamental Error.  
Basic energy requirements of cells such as the deformation and motility 
needs of white blood cells (wbc) are met by ATP synthesis in the mitochondria 
where the essential nutrient ubiquinone is required for oxidative phosphorylation.  
In addition, mitosis in any tissue requires ribose to copy DNA.  This is supplied by 
the hexose monophosphate shunt (HMS), most details of which have been well 
known in a number of tissues (fetal, wbc, etc) since the 1960's.  In wbc, both ribose 
for mitosis of lymphocytes and H2O2 for phagocytes are obtained via the HMS.  In 
1971, the discovery by researchers at The Bowman Gray School of Medicine that 
HMS rate is proportional to intracellular ascorbic acid (AA) should have changed all  
fields of medicine (Cooper et al 1971).  Because wbc were used for this work 
(instead of fetal or etc.), at least the immunologists should have immediately 
changed their thinking on AA.  Certainly, most of them read "Infection and 
Immunity".  In 1971, immunologists should have realized explicitly that intracellular 
AA, as measured by buffy coat (wbc) AA: (1) gives a prompt indication of immune 
status; and (2) is a universal limiting factor that determines the rate and intensity of 
cell mediated immune response (cmi). In humans and in AA-synthesizing 
mammals, lymphocytes multiply more rapidly and phagocytes ingest and kill more 
effectively when their intracellular AA, is high (as well as certain vitamins that, like 
AA, are also antioxidants, such as vitamins E and B6) (Grimble 1997; Penn et al 
1991).  In this era, it is as absurd as laughing at the germ theory to cite a 
Recommended Dietary Allowance (such as ~60 mg/day) for AA (called vitamin C 
although not a vitamin).  The ~50mg/kg body weight synthesized daily by all 4000 
normal mammals in the unstressed state is the actual requirement for AA in 
humans and all other non-synthesizing  mammals  (Pauling 1987).  Possibly, the most 
lethal misconception of our time is the notion that AA is a vitamin.  This notion is a 
major factor in the vast M&M cited by WHO 2000. 
Thus, the assumption that the refined diet is adequate and that essential nutrients 
can be omitted safely, without serious or fatal consequences, is profoundly flawed. This 
flawed belief is especially striking for AA and for ubiquinone, and has similar but less 
severe consequences for other essential nutrients.
Glycemic Modulation of the HMS. 
Three decades ago, after reading the Bowman-Gray 1971 report, we deduced 
and related to Linus Pauling a theoretical reason for the failure of clinical trials of AA 
against colds and cancer—the high blood glucose levels in developed nations. This 
theory is called “Glucose-Ascorbate Antagonism” (GAA). We extended this theory 
experimentally and obtained supporting findings in aging, birth defects, cancer, 
infectious diseases, and others (Ely 1981, 1996a,b; Santisteban et al 1985; Hamel et al 
1986; Ely et al 1988; Ely and Krone 2002,a,b; Krone and Ely 2001, 2004) (see Section 3 
below). A very high world wide correlation of cancer incidence with sugar consumption 
has been reported (Hems 1978; Carroll 1977; Michaud et al 2002; Nilsen and Vatten, 
2001; Schoen et al 1999; Augustin et al 2003). Our theory, supported by human and 
animal studies, suggests that the most common factor increasing tumor tolerance in 
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developed nations is the gross elevation of mean blood glucose (Sanisteban et al 1985; 
Ely 1996a).  A prominent example of the diseases of affluence is the estimate that about 
one-fourth of those alive today in these nations will present with clinical cancer during 
their lifetime. The GAA predicts that such individuals can be identified approximately as 
the older half of the upper half by sugar consumption. The basis for this prediction can 
be seen in two more statistics of the affluent societies:  (1) ~30 times more cancer occurs 
above age 55 than below 35; and (2) the 2-hour value on glucose tolerance tests rises 
10% per decade of age (Ely 1996b; Ely and Krone 2002a).
We sometimes think of the HMS as paradoxical because its rate varies inversely 
with the concentration of its substrate, glucose. The GAA is important in the normal 
(low-dose) range of ~10 g/day or less AA. The theory states that the intracellular AA 
levels in certain cell types, such as leukocytes and fetal cells, are ‘pumped up’ by insulin-
mediated active transport to the measured concentrations, ~50 times higher than in the 
surrounding plasma. This increase of intracellular AA occurs effectively if blood glucose 
is in the low range—50 to 90 mg/deciliter (mg/dL). This blood sugar was considered 
normal until the 1900s and is still seen where a primitive (unrefined) diet prevails, but it 
is approximately half the glycemic levels typical of affluence (Ely 1996a; Chatterjee and 
Bannerjee 1975).
Leukocytes require high AA levels to drive the HMS to supply adequate 
hydrogen peroxide and ribose for effective phagocytosis and mitosis. In even ‘modest’ 
blood glucose elevations (over ~130 mg/dL, common following most western diet 
meals), blood glucose molecules so outnumber AA that they competitively inhibit 
insulin-mediated active transport of AA into cells (Hutchinson et al 1983). Such 
inhibition results in low intracellular AA levels, low HMS, and cell dysfunction (namely, 
leukocytes don't attack tumors or pathogens, fetal cells divide too slowly, and so on); 
this phenomenon is the glucose ‘antagonism’ of AA. A principal cause of cardiovascular 
disease (cvd) is hyperglycemia, which reduces AA to scorbutic levels in vascular intimal 
cells. The GAA theory gives rise naturally to the use of controlled hypoglycemia 
concurrent with AA in the low-dose range (below 10 g/day). This modality is called 
Aggressive Glycemic Control (AGC) and appears to have much value against many 
disorders. In the high-AA dose range, it can out-compete glucose for insulin and elevate 
intracellular AA, accelerating the HMS.
Ignorance of GAA and AGC was most likely responsible for the unimpressive 
showings of the three large scale North American cold trials. This ignorance, certain 
other misperceptions, and deliberate misrepresentations, all well-cataloged and clarified 
by Pauling (1987), are also responsible for many erroneous views on AA, and much 
M&M.
On Controlled Hypoglycemia.  
Cancer, infections and other diseases (cvd, etc) have been shown to exhibit a 
much lower incidence and more rapid remission with adequate AA, and with blood 
glucose in the 50 to 90 mg/dL range (Murata et al 1982; Riordin et al 1985; Rivers 1989). 
Such glycemic control can be achieved by conforming to an unrefined diet, moderate 
caloric restriction, and as much physical activity as ones physician approves. In insulin-
coma therapy, formerly used in the treatment of psychiatric disorders, blood glucose 
was maintained circa 30 mg/dL, serendipidously maximizing intracellular AA. In this 
therapy, remissions from cancer were reported to occur in patients whose incurable 
malignancies were unknown to the psychiatrist at the time of treatment (Koroljow 
1962). A more practical approach for AGC, avoiding the difficulties and dangers of 
coma, might be to maintain blood glucose at 50 to 60 mg/dL with exogenous insulin or 
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Orinase (a non-halogenated oral hypoglycemic). 
SECTION 2.  Ascorbic Acid Is Not a Vitamin 
Overview 
For all mammals, including humans, vitamins are essential nutrients that are 
needed in only minute amounts to provide optimum health (Lehninger 1982). We show 
herein that ascorbic acid (AA) is needed in large amounts and therefore, is not a 
vitamin,  although it is commonly called "vitamin C".  We list many other reasons why 
this is so.   The "vitamin" identity was mistakenly assigned to AA about 20 years before 
its 1927 discovery by Nobelist Albert Szent-Gyorgyi who later, with another Nobelist 
Linus Pauling, both showed AA was not a vitamin (Pauling 1987; Stone 1972).  The 
mistaken view that AA is a vitamin is immediately apparent from the following: about 
4000 mammals synthesize AA, on average circa 150 mg/kg body weight daily (vastly 
more in stress) or about 10 g/day, normalized to 70 kg "human" weight (see Pauling 
p.98, line 6 and p.100, line 1). Humans are in a very small subgroup of 5 mammals that 
has lost the ability to synthesize AA (Chattergee 1973).  However, the human has the 
same needs per kg as the 4000 normal mammals who still synthesize AA.  If less than 
that amount of AA is acquired, a rise occurs in incidence of virtually all diseases, 
including infections and cancer, rapid aging and early death. This is mistakenly 
considered  normal morbidity and mortality (M&M) by those not aware of the 
numerous major needs for AA in multigram quantities. This for example occurs in the 
replacement of structural proteins in resistance to aging and disease.  To explain how 
such mistaken views could persist so long, we note that in all of past history, and 
perhaps throughout the future, people will suffer ailments with causes and possibly 
cures that have no known logical basis or scientific explanation.  Much of medicine is 
compelled to either accept or deny these empirical associations.  Thus, empiricism has 
long been a guide of medical practice.
In early mammalian evolution, synthesis of AA evolved to provide this versatile 
endogenous molecule to control, organize, drive and take part in many vital processes 
(Stone 1972).  It was only by accident, that a very few mammals in the tropics obtained 
enough AA in their food to survive a low stress environment without endogenous 
synthesis.  Freedom from the need to synthesize AA gave a genetic advantage to these 
animals until they left the tropics.  Pauling (1987, 1991) and others have reported that, 
rather than milligrams, several grams (over ten in many people) a day of ascorbic acid 
(AA) are absolutely necessary for numerous aspects of optimum health in humans. The 
confusion over AA's non-vitamin nature has been prolonged by continued use of the 
misnomer "Vitamin C" for communication convenience by those who knew better 
(even Pauling).
The large quantities of AA shown above to be synthesized by normal mammals have 
been found to be essential for optimum health (Chattergee et al 1975; Pauling 87, 91; Ely 
1999). When in stress (e.g., pain, fear, disease, etc.), the needs and synthesis are far 
higher (~100 fold!) (Lewin 1976, p.109).  Such mammals, often called "normal", were 
here on earth long before humans. It is important to note that, in the wild state, the 
normal mammals do not get scurvy and do not consume a refined diet (i.e., their free 
sugar intake is very low).  They developed and used AA as an important endogenous 
molecule that is necessary in such large quantities for essentially all systems and 
functions. AA enables all normal mammals to resist most diseases, intoxications, and 
other disorders of humans including tuberculosis, polio, etc. In the human body, there 
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are thought to be about 50,000 different kinds of enzymes, a large number of which are 
influenced by AA (Pauling 1987, p.87).  As AA levels fall, many enzyme systems fail, 
disorganizing numerous physiologic functions (King 1967).  The human need for AA is 
the same as that of the normal mammals (Pauling 1987, Chap 9).  When this need is met 
and their blood sugar is maintained at a low level as described later, humans are also 
protected.
The normal mammals meet the fluctuations in AA need automatically over a wide 
range of conditions due to the adaptability and efficiency of a global endocrine 
synchrony.  Unfortunately, the human as a non-synthesizing mammal, does not have 
this synchrony but is burdened with the same daily AA requirements.  Thus, humans 
have the life-long need (not an option!) to supplement inefficiently an amount that is 
unavoidably greater than the basic normal mammal need.  Simply providing humans a 
calculated amount of ~150 mg/kg body weight as one or a small number of doses (oral 
or other) on a fixed schedule will not replicate the sufficiency seen in normal mammals.
We cite many reports (from a much larger number) demonstrating that high AA is 
required for optimum or "full health" as defined to be "the greatest resistance to disease" 
by  Albert Szent-Gyorgyi, the Nobel Prize winner who first isolated AA (Stone 1972, 
p.xi).  He also said AA was not a vitamin, and "The medical profession itself took a very 
narrow and wrong view: Lack of ascorbic acid caused scurvy, so if there was no scurvy 
there was no lack of ascorbic acid." (Stone 1972, p.xi).  Linus Pauling, the only holder of 
two unshared Nobel Prizes explained at great length why AA is not a vitamin (Pauling 
1987, Chap 9). He also estimated that most people get only 2% of the AA necessary for 
full health (Stone 1972, p.x).
In essence, the benefits of high AA in the synthesizing mammals are so great and the 
countless costs of low AA (due to the "vitamin view") in humans are so tragic that 
neither could be an accident.  To think of AA as a vitamin is a lethal error.  It dooms the 
thinker to rapid aging, much illness with related suffering, medical costs, and early 
death.  When AA first became available in the 1930's, its impressive effects in infectious, 
as well as, degenerative and other diseases stimulated extensive world-wide research 
and clinical activity resulting in publication of over 10,000 papers by 1975.  Hundreds of 
these were carefully reviewed in the book by Irwin Stone (1972) the biochemist who 
introduced Pauling to AA.  However, successes of AA in clinical trials against colds and 
cancer in the 1960's and 70's were compromised by the high blood glucose levels 
accepted as normal in developed nations (Ely 1981, 1996a,b; Santisteban et al 1985; 
Hamel et al 1986; Ely et al 1988). Until the 1900's, the low-sugar, whole-grain, unrefined 
diet produced 2-hour postprandial blood glucose values of 50-90 mg/deciliter.  These 
are still seen where the primitive diet prevails (Chatterjee and Bannerjee 1979, Tab.1 
footnotes) and are approximately half the glycemic levels typical of affluence today (Ely 
1996b). Listed below is a sampling (from a much larger number) of ways in which it 
was shown decades ago that AA at high doses gives "full health".  Although it was not 
understood at that time, it is now known how and why this was so.  As described in 
more detail above, hyperglycemia opposes AA because glucose competitively inhibits 
the insulin mediated active transport of AA against the high gradient; in health, AA in 
cells is ~50 times the plasma level (Lewin 1976, p.78). The inability to raise INTRAcellular 
AA to optimum levels, because of hyperglycemia (GAA), compromises all biochemical 
processes. The correlations between dietary factors (e.g., high sucrose, meat and animal 
fat), and incidence and M&M for both heart disease and cancers of various types are so 
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strong, that WHO and numerous agencies and investigators are accepting them as 
indicating true causality (Carroll 1977, Skegg 2003; Scobie 2002; Ely and Krone, 2002a).   
New Zealand and the US have some of the highest sugar intakes and cancer rates in the 
world (Carroll 1977).
By the 1950's, the convenience of numerous antibiotics and vaccines had captured the 
attention of mainstream medicine and no one felt compelled to read the older literature 
or practice its methods.  AA was soon rejected as unpatentable and forgotten by 
mainstream medicine.  Nevertheless, in the last 50 years, many reports have been 
published by research oriented physicians of viral and bacterial diseases, intoxications, 
etc., successfully (safely and economically) treated by massive doses (from 10 to over 
200 grams (!) per day) of ascorbate.  If a normal mammal is responding to intoxication 
similar to chemotherapy in a human, the mammal is observed to increase its synthesis 
of AA so much that  it excretes in urine over 100 times as much AA as it normally has in 
its entire body (Lewin 1976, p 109; Longenecker 1939).  High levels of AA are needed in 
the liver to hydroxylate toxins so they will be excreted  in the urine and demethylate 
the toxins so they are not stored in the body fat (Tsao 1997).
SECTION 3.  Prevention and Cure of Major Disorders of Affluence
The effects discussed above are manifest and important in almost every bodily function 
and medical procedure in humans and other mammals. This includes those mammals 
that are "normal" (i.e., still synthesize their own AA circa 10 g/d normalized to 70 kg 
body mass) (Pauling 1987, p.98). A sampling is listed below in alphabetical order: aging, 
antitoxin, birth defects, cancer, cardiovascular disease, cold trial failures, infection and 
surgery.
Aging. The changes associated with aging can be strongly opposed by AA through 
several mechanisms (Ely and Krone 2002b; Krone and Ely 2004).  There is a large daily 
need of AA for the hydroxylation reactions necessary for synthesis of new connective 
tissue to maintain its youthful characteristics (Pauling 1987, p. 92). Maintenance of 
youthful flexibility and elasticity are necessary: (i) for the heart  and the arteries to 
provide maximum ejection fraction with minimum effort and backpressure; (ii) for 
pulmonary efficiency; and (iii) for leukocyte deformations in diapedesis and 
phagocytosis; etc.  The free radical theory of aging was proposed by Denham Harman 
in the 1950's (Harman 1969).  The antioxidant properties of AA can counteract the free 
radical damage.  Moreover, AA can oppose protein glycation, another commonly cited 
biochemical change associated with aging (Cerami et al 1987; Ely et al 1988; Krone and 
Ely, 2004).
Antitoxin. Today, we are susceptible to many conditions, frequently fatal, for which 
high AA has been suggested by both human and animal studies to offer an effective 
treatment. For example, it was reported to save the patient quickly in many forms of 
shock (Stone 1972, Chaps 24 and 27).  Many thousands of needless deaths occur each 
year from the bites of snakes, spiders, other insects, etc.  Klenner obtained rapid 
reversal of the swelling, pain, breathing difficulties, shock, etc, resulting from such 
"bites" using intravenous AA (350 to 700 mg/kg body weight) and AA p.o. as followup 
(Klenner 1971).  Similarly, Klenner normalized the shock in patients with barbiturate 
poisoning using intravenous ascorbate (12 to 75 g) (Klenner 1971).   More than 50 years 
ago high levels of AA had been shown to prevent or cure intoxications due to organic 
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chemicals (e.g., benzene) and heavy metals (Hg, Pb, As, mercurial diuretics, etc.) (Stone 
1972; Chapman 1947).  A second modern example of the mechanisms now understood 
for beneficial effects of AA is that, in Hg intoxication: AA has been found to enter brain 
cells and act as an electron donor, converting Hg++ to Hg°, thus mobilizing it and 
facilitating excretion via sweat (Ely et al 1999a).
Birth Defects. Gestational diabetes causes the more frequent of two types of very 
serious fetal injury arising from hyperglycemic antagonism of mitosis. One type 
produces major malformations in early and the other neurological defects in late 
pregnancy. The same mechanism of injury and method of prevention apply in each 
case. The mechanism, GAA (Ely 1981) and its proof are discussed above, and the theory 
has been cited in a review (Cousins 1983). In essence: (1) normal mitosis requires ribose 
from the HMS which runs at a rate proportional to intracellular AA, and fetal cells 
typically have the highest AA concentrations (fetal organs ca 180 mg %) recorded in 
human tissues (Lewin 1976, p. 78); but (2) hyperglycemia competitively inhibits insulin-
mediated active transport of AA into these cells, slowing mitosis. It was also shown that 
hyperglycemia of early pregnancy induces striking reproductive anomalies in an animal 
model  (Hamel et al 1986).  Thus, high levels of AA and low blood sugar can eliminate 
most birth defects.
Cancer. Neoplastic initiation occurs daily even in healthy humans but adequate AA 
produces basement membrane surrounding each cell that prevents metastasis.  Also the 
wbc will attack the cancer if glucose is low and AA is high leading to high leukocyte 
intracellular AA.  When cancer is being treated with chemotherapeutic agents, AA is 
needed to prevent the side effects by ensuring that the liver can metabolize these 
agents, as described above (Tsao 1997).
Cardiovascular Disease. To prevent cvd, not only is there a high need for AA in 
renewal of structural proteins (see above), but also high intakes of AA and E prevent 
the development of new lesions of the vascular intimal surface, if glycemic control is 
adequate.
Cold Trial Failures and rCHO.  The cold trials of the 1960's and 1970's failed because of 
the high blood sugars prevalent in affluent nations.  Blood sugar has a strong tendency 
to be higher in persons with a high rCHO intake.  The trials could be repeated using 
blood sugar (such as glycated hemoglobin (GHb)) as an independent variable. Then it 
would be found that persons with very low GHb had low incidence and low severity of 
colds because their AA was largely intracellular as explained above.  Those persons with 
high GHb (and therefore low intracellular AA) would have high incidence and severity 
of colds.
Infectious Diseases 1. In the 1930's, the remarkable Claus W. Jungeblut, MD, worked in 
the College of Physicians and Surgeons of Columbia University.  He first reported that 
AA in concentrations, attainable in humans by a high intake, could inactivate and or 
protect against numerous viral and bacterial pathogens and their toxins (Pauling 1987; 
p.166; Jungeblut 1935a,b, 1937).  These include the polio, hepatitis and herpes viruses, 
etc. Many other researchers have published in vitro, in vivo, animal and human 
evidence of AA's almost universal ability (bacteriostatic, bactericidal, virucidal, etc.) to 
prevent and cure infections.  One of the earliest research findings was AA's ability to 
neutralize and render harmless many bacterial toxins (e.g., tetanus, diphtheria, and 
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staph toxins) (Stone 1972; Jungeblut 1935b, 1937).  It has been clearly demonstrated that 
oral AA 2 g daily protects against post-transfusion hepatitis (Pauling 1987). The high 
safety, efficacy and economy of AA have been proven, and low levels of AA greatly 
predispose to infectious diseases (Jungeblut 1935a,b, 1937; McCormick 1951). 
Infectious Diseases 2. Another ingenious physician-researcher, Fred R. Klenner, MD 
(from Duke Medical School 1936), was originally a chemist and a PhD student in 
Physiology.  He was inspired by Jungeblut and the fact that AA is an essential nutrient, 
not a vitamin.  As a result, he perfected high dose AA therapy and used it for many 
infectious diseases and other disorders (Klenner 1949, 1971, 1974).  He reported that 
early dosing with amounts that elevate wbc AA sufficiently (50-100 g/d by iv and/or 
oral)** produces prompt (3-7 day) cures of polio, viral encephalitis, acute hepatitis (all 
types), adenovirus, chicken pox, measles etc.  Robert F. Cathcart, MD, world famous for 
his work in orthopedic surgery at Stanford, adopted and extended the work of Klenner, 
treating over 30,000 patients.   His innovations include a simple method called "titrating 
to bowel tolerance" (TBT) dosing that permits a very sick outpatient to administer AA in 
exactly the correct oral dose each day for influenza, glandular fever, etc (Cathcart 1981, 
1984).   Treatment protocols and results for high-dose AA have been reported in detail 
by Klenner (1949, 1971, 1974), Hoffer (1971, 1991), and Cathcart (1981, 1984).
** In iv dosing, AA is always sodium ascorbate.
The amount of AA that humans can get from food alone is more than adequate for 
prevention of TB but not pertussis and far below that required to treat these diseases.  
As per the literature, TB is one of the easiest diseases to prevent  because the AA 
bacteriostatic level is only 1 mg% (i.e., even below the AA renal threshold 1.4 mg%) 
(Boissevain 1937).  The AA bactericidal level for TB was shown to be 10 mg% by Sirsi 
(1952).  But, TB patients require much higher AA doses to maintain a given AA level 
than is observed in other diseases.  It is surprising that nearly all of the many authors 
reporting (in 1930's and 1940,s) on use of "vitamin like" AA doses stated it improved TB 
patients, but they never tried multi-gram doses (cost may have been a factor). Of 
course, as explained earlier, if their AA-synthesizing ability had not been lost, humans 
would be immune to TB without AA dosing.
Surgery.  For years, surgeons have expressed much interest in factors that could 
facilitate wound strength, healing rapidity, and freedom from infection.  All three of 
these conditions are strongly influenced by ascorbic acid (AA). Recently, a large scale 
ongoing clinical study of critically ill surgical patients has shown many benefits in those 
given multi-gram AA and vitamin E (Nathens et al 2002).  Yet, it has been known for 60 
years (Bourne et al, 1946; Bartlett 1942) that scar tissue is much stronger in guinea pigs 
and humans with high intake of AA; the strength of the scar tissue increasing linearly 
with the AA dose. In 1941, it was shown that human unhealing wounds of 7 months 
duration healed rapidly when 1 g AA/day was given for 10 days (Lund 1941). And, 
medicine as a whole has shown little interest in the fact that patient AA is commonly 
low at surgery and falls precipitously in surgery, trauma or other stress (Pauling 1987; 
Stone 1972; Crandon et al 1958). Hume reported the dangerous fall of white blood cell 
AA to scorbutic levels within 12 hours after heart attack in 31 consecutive patients 
(Hume et al 1972).  When AA is used at high levels, vitamin E need is increased because 
it prevents clotting without causing a hemorrhagic tendency (Ochsner et al 1950; 
Ochsner 1964).
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No valid argument or experimental evidence supports the concept that "AA is a 
vitamin". The fact that AA is not a vitamin has been proven countless times.
SUMMARY AND CONCLUSIONS
As cited above, it is established by unquestioned authorities including CDC and 
WHO that over 1 million patients receiving TOC have suffered and died annually 
for decades in the US.   Included in this annual M&M were approximately 700,000 
cvd, 500,000 cancer, 200,000 infection and 150,000 stroke patients.  Although 
physicists and other scientists who perished in this toll were capable of 
understanding the erroneous beliefs of organized medicine explained herein, they 
may have trustingly assumed TOC's were the best modalities.  Physicists et al who 
have read this far, likely now understand the errors of TOC's and the rationale of 
the highly effective therapies that had been rejected as unprofitable.  Likely, most 
or all of these scientists now recognize the real peril that they, their families and all 
of us are suffering today.  It is expected most of these physicists will urge the UCS 
to cite this LANL in the UCS Newsletter to stimulate action to disempower  the 
Medical Quality Assurance and Medical Disciplinary Boards and the TOC's they 
enforce.
See Chapter 2, "Dental Mercury Amalgams and the Biochemical Relationship with 
Micromercurialism, Retention Toxicity and Extreme Psychoses (Serial Killers with 
No-Remorse)",  below these references.
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CHAPTER 2: Physical Characteristics and Effects Reported for Some High-
Copper Dental Mercury Amalgams and the Biochemical Relationship with 
Micromercurialism, Retention Toxicity and Extreme Psychoses (Serial Killers 
with No-Remorse)
INTRODUCTION
The so-called “Amalgam Wars” have gone on for close to 200 years and controversy 
regarding safety of dental amalgam continues to circulate among government 
regulatory/legislative bodies, the dental/medical community and the general public.  
This is despite the undisputed fact that Hg is a potent neurotoxin and the mounting 
research evidence in humans that dental amalgam fillings release significant amounts 
of Hg vapor and persons with larger numbers of fillings have greater body burdens 
of this toxic element.  Herein, we mention briefly physical/chemical factors that can 
affect mercury release from dental amalgam (DA) (e.g., chemical composition, 
intermetallic forms, mechanical stresses, temperature, acidity, etc).   Also discussed is 
a proper model of mercury toxicity created and accepted by world experts. The 
model makes clear how and why any person might enter a state called 
micromercurialism (MM) without any idiosyncratic predisposition. Dental amalgam 
Hg has been cited as the cause of intoxications that range from the almost 
imperceptible (tremor, memory, fertility) through severe illness in dental patients 
(Alzheimer disease and motor neuron disease), to suicidal behavior and serial killers 
with no-remorse (Bundy, Green River, OKC-Bomber, etc, etc).  Dag Brune and other 
experts have performed research studies that demonstrate conditions that  suggest 
millions of people likely are suffering each day because of these neglected amalgam 
toxicities.
THE AMALGAM WARS.  
Mercury dental amalgams in restorative dentistry have faced opposition for nearly 
200 years.  The first use of mercury amalgam as a dental filling occurred in the 1820’s 
in Paris France.  These first formulations tended to expand upon solidification and led 
to fractured teeth.  The Crawcour brothers from Great Britain began a dental practice 
in New York City in 1833 despite the fact that they were not dentists.  They 
advocated a “new” amalgam of silver and Hg as a cheaper and easier-to-apply 
substitute for gold fillings.  The Crawcours were very successful and competing 
dentists assembled a vigorous opposition to mercury fillings, in large part because the 
fillings caused very serious mercurial poisonings, diseases of the gums, etc.  Several 
American associations for dentists banned the use of dental amalgam and even 
suspended members  for malpractice for using mercury amalgam.  However, some 
continued to experiment with “silver” fillings and worked to achieve the proper 
balance between the silver (which leads to expansion of the amalgam) and tin (which 
leads to contraction).  By the beginning of the 1900’s, a “stable” formulation had been 
developed and waning opposition seemed to have ended this “First Amalgam War” 
The “Second Amalgam War” began in ~1926 when the German chemist, Professor A. 
Stock, began a warning campaign against mercury.  Micromercurialism (MM) is a 
term coined by Stock in the 1920’s and widely used to denote chronic intoxication 
from long term exposure to low levels of Hg vapor.  Stock also demonstrated (in 
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himself) that MM can be caused by dental amalgams.  Stock stimulated a wave of 
scientific interest in MM in Germany and Russia (which adopted the lowest tolerable 
work place Hg vapor levels in the world, 10 and 1 µg/m3, respectively) (Patterson et 
al. 1985; Gerstner and Huff 1977).  Stock’s campaign was  overshadowed by events of 
World War II in Europe and it was not until the early 1980’s that Swedish scientists 
including Jaro Pleva, Magnus Nylander, Mats Hanson and many others initiated the 
“Third Amalgam War”.  This war continues today with professional dental societies in 
the US maintaining their position that Hg amalgams are “safe and effective” in spite 
of the now overwhelming evidence that Hg is released from dental amalgam and 
accumulates in the tissues of persons with Hg dental fillings (Guzzi et al. 2006). 
THE CHEMICAL/PHYSICAL NATURE OF AMALGAM AND HG VAPOR 
RELEASE
The composition of the most common dental amalgams are intended to have about 
50% Hg.  Silver and tin are the other major components.  The addition of copper (up 
to 30%) in recent times has increased in prevalence.  In general, DA is formed by 
mixing Hg with the other elements (Pleva 1989, 1994). Although a wide range of Cu 
content (from about 10 to over 30%) has been used in high-Cu DA for the last two 
decades or so, several of the more popular have about 12% Cu (instead of the 
formerly more common 3%). Two reasons suggested for the development of these 
“high-Cu” amalgams were the better structural characteristics (smoother finish and 
longer holding of edges) and the lower cost of Cu versus Ag.  It is reported that the 
ADA owns the patents for the high-Cu formulation used by most dentists in the US 
(Null and Feldman 2002, p.101).
However, an extremely hazardous unforeseen outcome resulted from the high-Cu 
formulations.  Rather than creating a more stable DA, the high-Cu formulations 
under the conditions in the human mouth emit much more Hg vapor than 
conventional amalgam (Brune et al. 1983).  A typical property of the modern high-Cu 
DA is the “sweating out” of Hg droplets (Pleva 1994).  It has been reported that one 
of the widely used 12% Cu amalgams releases Hg about 50 times as fast as the 3% Cu 
(Brune et al. 1983); see Abstract, Fig. 4, and page 70, top paragraph in right column.  It 
is trivial to demonstrate with a Jerome 411 Hg Vapor Analyzer that high Cu 
amalgam does release Hg much faster (Ely 2001b).  In hundreds of subjects, it was 
found that even when > 10 years old these amalgams commonly released Hg ≥ 2 
times the rate of the conventional 3% Cu.
MERCURY TOXICITY AND THE PROPER MODEL 
We describe a proper model of mercury created and accepted by world experts with 
no financial interests in dental amalgam; these include Dag Brune, Boyd Haley, 
Joachim Mutter; Magnus Nylander, Victor Penzer, Jaro Pleva, Patrick Stortebecker, 
etc.  The model makes clear how and why any person might enter a state called 
micromercurialism (MM) without any idiosyncratic predisposition.  Initially, 
essentially every human has some chronic exposure to ambient environmental Hg 
that does not exceed the person's excretory ability.  If the chronic exposure rises due 
to any cause (workplace, dental amalgams, etc), a level of intake can be reached that 
exceeds the subject's excretory ability.  Then, according to the model, the 
accumulation of Hg is not simply the difference between intake and the original 
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excretory ability, but rapidly becomes much worse, approaching the total intake.  The 
theoretical reason is that the rising soft tissue Hg burden inactivates the enzymes 
involved in excretory processes (presumably by bonding as Hg++ to SH groups).  It 
is well known that Hg strongly inhibits enzymes (Webb 1963), which can lead to 
greatly diminished excretion, a condition now called "retention toxicity", and the 
associated diagnostic difficulties (i.e., low urine Hg excretion; <5 µg/day).  Diagnosis 
of MM frequently hinges mistakenly on urine Hg values intended to detect acute 
intoxication (i.e., normal values (0-20 µg/L) and "toxicity" (>150 µg/L)). A 1938 Public 
Health Service study of MM in hatters published in JAMA, showed that those with the 
highest body burdens and who were the most intoxicated exhibited the lowest urine 
Hg (Neal and Jones 1938), and thus were in "retention toxicity".  According to the 
proper model, most MM subjects initially exhibit retention toxicity and very low urine 
Hg (i.e., 0-5 µg/d). 
People who excrete Hg well do not retain it and can tolerate large intakes, 
maintaining low blood levels and preventing diffusion of Hg into bone storage.  In 
retention toxicity, the decreased excretion and rise in blood levels are associated with 
diffusion of Hg into the skeleton where large body burdens can accumulate in bone 
storage (Bloch and Shapiro 1981). It has also long been known from x-ray 
fluorescence studies that persons with chronic Hg exposure such as dentists, have 
elevated skeletal Hg stores (Bloch and Shapiro 1981), as well as, low urine Hg (Neal 
and Jones 1938).   If the source of exposure is eliminated (environmental or 
amalgams), subjects recover from retention toxicity and exhibit elevated Hg 
excretion, sometimes for many years from bone storage (in agreement with both the 
proper model and measurements by world experts).  Moreover, in old age, 
osteoporosis may accelerate Hg release to a rate somewhat above that corresponding 
to the 20 year excretion half-time estimated by Sugita (1978).  As a result of these 
complexities, there is almost no awareness of the degree of Hg intoxication in the US 
today or its impact on the incidence of Alzheimer’s disease (AD), Parkinsons, suicide, 
psychoses, etc. 
The diagnosis of MM is always missed by most physicians who misinterpret the 
resulting low (or "unmeasurable") urine Hg (Ely et al 1999) as indicating no 
intoxication.  Low urine Hg is MULTIPLY MISTAKENLY interpreted today almost 
universally as evidence of low intoxication attributed to low exposure, also falsely 
attributed to careful Hg-handling practices in the clinics.  In a US study of 6925 
dentists, 90% had urine Hg concentration below 6 µg/L (Echeverria 2002).  This study 
and it's very low value have been cited many times and misinterpreted to indicate 
very low intoxication and low exposure due to (allegedly) high levels of control in 
dental clinic atmosphere**.   In fact, anyone with amalgams or occupational exposure 
will have urine levels two or more times above this low value unless in retention 
toxicity (urine Hg <5µg/day). The few physicians who diagnose Hg intoxication 
correctly realize such impairment of excretion will worsen until exposure stops or the 
patient dies.
**Editors of a dental “journal” have been quoted as claiming that “amalgam is a 
stable alloy similar to sodium chloride” (found by Mutter et al. 2004a, p.393). 
The "Expert" Problem.  Intoxication is a normal concern of physicians who understand 
and can treat acute intoxication by Hg as occurs in lab/industrial spills, etc.  In recent 
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decades medicine has decreased use of Hg in medicinals but has relied on the dental 
profession to police the amalgam Hg toxicity question.  In 1991, the FDA and the 
AMA sided with the American Dental Association on the supposed safety of amalgam 
and all called for more research to allay public fears on the issue.  However, 
Stortebecker had shown and warned that Hg levels in the mouth (and in brain by 
“shortest pathway”) due to dental amalgam were much higher than occupationally 
permitted (Committee on Mercury Compounds 1969). MM differs in many respects 
from the generally recognized acute form of Hg intoxication.  These differences, 
which were recently elucidated (Ely et al. 1999), are responsible for almost universal 
failure of today’s physicians to diagnose MM. Thus, it is unfair to expect anyone with 
today’s training in medicine to be aware of the basics on MM.
DISORDERS, INCLUDING PSYCHOSES, ASSOCIATED WITH 
MICORMERCURIALISM
The MM disorders are believed (by research scholars) to range from the innocuous 
(such as hand tremor) to serious neurological diseases (including ALS, Alzheimer's, 
MS and Parkinson's) (Stortebecker 1986) and to the frank psychoses of the hatters, 
light-house keepers, and Newton whose madness ended one of the most productive 
scientific careers in history (Klawans 1991).  Several studies have reported links 
between suicidal behavior and occupational mercury exposure (e.g., dentists and 
mercury miners), as well as, in subjects exposed only to amalgam Hg (Guzzi et al. 
2006; Ametz et al 1987; Grum et al 2004).  Dental amalgam (DA) Hg may even be 
associated with serial killers characterized by “no-remorse” (i.e., Green River Killer, 
OKC bomber, Post Office Massacres, Unibomber, etc).  Much evidence that supports 
the seemingly bizarre (but easily testable) hypothesis that the wave of unprovoked 
homicidal behavior (characterized by no-remorse) (that some say is sweeping the US) 
may have, dental Hg as a major factor.  We propose that this has become much more 
probable with the increasing popularity of the "high copper" type of dental 
amalgams.
Obviously, not all individuals who receive one or more of the 100 million amalgams 
that are placed each year in the US become no-remorse killers.  However, there are a 
number of factors that can greatly influence the magnitude of the body burden and 
symptoms (including no-remorse) that result from amalgam Hg.  It has long been 
evident from the literature that prolonged (chronic) exposure of humans and animals 
to extremely low levels of mercury (Hg) and or lead (Pb) result in storage of these 
metals in the skeleton** from which they slowly leak out to the brain causing a great 
variety of  neurological and psychiatric disorders.   If only Hg is involved, chronic 
intoxication is called MM.  At the present time, widespread use of the newer "high-
copper" amalgams (that release mercury 50 times as rapidly) has changed the 
intoxication to an extreme form of MM. 
**(at many times the brain levels that incapacitate in acute exposure).
Although Hg alone at levels attainable in the body from amalgams can cause 
psychoses or other intoxication, very much smaller amounts of Hg when combined 
with even smaller amounts of Pb have been reported to produce toxic effects 
including death in animal models.  This Pb-Hg Synergism was discovered by Schubert 
(1978) who reported that a very small dose of Hg (LD1, the dose that should kill only 
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1% of the animals) plus an even smaller dose of Pb (1/20 LD1) exert an amazing 
synergism (possibly via enzyme inactivation) to produce an LD100 effect killing all 
the animals!  Evidence of the same synergism was recently reported in humans by 
Godfrey and Campbell (1994).   In spite of low Pb gasoline, militia and others who 
regularly use firearms still have Pb exposure from firing ranges as well as Hg from 
amalgams and may be at risk for this synergism.  
Many people do not absorb sufficient Hg systemically from their dental amalgams to 
cause overt disease.  However, there are three factors that differ so greatly from 
person to person that, in theory, two individuals with the same amalgam geometry 
can differ in the Hg absorbed by a factor greater than 100,000 fold!  Estimates suggest 
that only 5 to 10% of the amalgam wearing population may be at significant risk for 
serious disease.  In addition to the greater release of Hg from the high copper 
amalgams, two physiological factors can greatly enhance Hg exposure.  Mouth 
breathing (i.e., sleeping, exercising, etc., with the mouth open) can increase 
absorption 4000 times!  Clenching, bruxing, or chewing increases release rate about 
ten fold.  Thus, according to published testable figures, absorption can be increased 
400,000 times in a person with all three of these factors (Ely 2001a).  
THE FAILURE OF MEDICINE AND DENTISTRY 
The "Mercury Wars" have occurred because the level of science in the US was unable 
to prepare medicine and dentistry to understand MM and two of its principal 
characteristics (retention toxicity and bone storage).  It is unfortunate (although 
certainly understandable) that physicians refused to supervise the medical aspects of 
amalgams.  Naturally, medicine wasn’t interested in tooth fillings.  Physicians aren’t 
aware of these matters. For example, physicians  in general and even most dentists 
don’t understand that lower urine Hg indicates higher mercury poisoning.  So, again 
the physicians have not been prepared to be a help to this cause. 
DENTOLOGY
It is proposed that there be a specialized branch of medicine (dentology).  The 
students will have the same curriculum of courses that normally constitute medical 
school training.  It is conceivable that students can transfer during pre-med years and 
possibly even during medical school with approval of the institution.  In a similar 
fashion, the interns may transfer with approval of the departments concerned.
TESTS OF THE HYPOTHESIS.   
Uneducated public feeling against those who commit loathsome acts of violence is 
understandably punitive and would be against tests that might show that the 
"criminals' behavior" was or might have been due to intoxication arising in the 
manner considered here.  However, if the hypothesis is correct the very safety of the 
country is at risk; we cannot afford to allow this possibility to go unstudied. To test 
the Hg no-remorse hypothesis would involve determining: (1) if the subject currently 
has, or has had in the past, amalgam dental fillings; (2) the type of amalgam (e.g., 
high copper); (3) the number of amalgam fillings; and (4) presence of the other 
susceptibility factors mentioned above.  If it appears from this initial screening that 
Hg might be implicated, further medical testing would be warranted. The placing 100 
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million amalgams per year in the US should be investigated and stopped.
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